Status:
COMPLETED
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Sinusoidal Obstruction Syndrome
Colorectal Liver Metastases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to determine whether anticoagulant use (i.e. salicylates, clopidogrel, low-molecular weight heparin, or coumarin derivates) is able to prevent the development of the sinuso...
Detailed Description
Surgical resection remains the only curative treatment for patients suffering from colorectal liver metastases, but only 15-25% of patients are initially eligible for resection. The majority of patien...
Eligibility Criteria
Inclusion
- age \> 18 years
- colorectal liver metastases that are eligible for resection
- operated from January 2008 up until December 2009 at Maastricht University Medical Centre
Exclusion
- irresectable colorectal liver metastases
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00885950
Start Date
January 1 2008
End Date
June 1 2010
Last Update
February 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery; Maastricht University Medical Centre
Maastricht, Netherlands